Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ·Healthcare·Biotechnology
$519.54
-0.06%
Mkt Cap $12.11B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 19, 2026 | $312.51M | $321.10M | +2.75% | $0.04 | -$2.57 | -6525.00% | — | — |
| Q4 2025 Nov 4, 2025 | $244.96M | $287.27M | +17.27% | -$2.04 | -$5.08 | -149.38% | — | — |
| Q3 2025 Aug 5, 2025 | $243.47M | $212.80M | -12.59% | -$3.48 | -$1.90 | +45.40% | — | — |
| Q2 2025 May 1, 2025 | $158.93M | $137.25M | -13.64% | -$3.62 | -$3.32 | +8.29% | — | — |
| Q1 2025 Feb 26, 2025 | $97.81M | $103.32M | +5.64% | -$4.32 | -$2.71 | +37.27% | — | — |
| Q4 2024 Oct 31, 2024 | $92.53M | $62.17M | -32.80% | -$6.94 | -$4.92 | +29.11% | — | — |
| Q3 2024 Aug 7, 2024 | $3.90M | $14.64M | +275.33% | -$7.55 | -$7.10 | +5.96% | — | — |
| Q2 2024 May 7, 2024 | $3.90M | — | — | -$6.06 | -$7.38 | -21.78% | — | — |
| Q1 2024 Feb 28, 2024 | — | $770.00K | — | -$5.32 | -$5.68 | -6.77% | — | — |
| Q4 2023 Nov 6, 2023 | — | — | — | -$4.78 | -$5.34 | -11.72% | — | — |
| Q3 2023 Aug 8, 2023 | — | — | — | -$4.47 | -$4.69 | -4.92% | — | — |
| Q2 2023 May 9, 2023 | — | — | — | -$4.98 | -$4.23 | +15.06% | — | — |
| Q1 2023 Feb 23, 2023 | — | — | — | -$4.41 | -$4.98 | -12.93% | — | — |
| Q4 2022 Nov 3, 2022 | — | — | — | -$4.05 | -$4.75 | -17.28% | — | — |
| Q3 2022 Aug 4, 2022 | — | — | — | -$3.76 | -$4.14 | -10.11% | — | — |
| Q2 2022 May 9, 2022 | — | — | — | -$3.75 | -$3.36 | +10.40% | — | — |
| Q1 2022 Feb 24, 2022 | — | — | — | -$3.92 | -$3.78 | +3.57% | — | — |
| Q4 2021 Nov 4, 2021 | — | — | — | -$3.89 | -$3.79 | +2.57% | — | — |
| Q3 2021 Aug 5, 2021 | — | — | — | -$3.55 | -$3.72 | -4.79% | — | — |
| Q2 2021 May 6, 2021 | — | — | — | -$3.78 | -$3.32 | +12.17% | — | — |